Evidence map›Paper›PMID 40596462›Full record

Observational studyScientific reports2025

Prevalence, practice pattern, and mortality of hyperkalemia in Chinese patients undergoing hemodialysis in the visualize HD study.

Zhao Xinju, Xing Changying, Liu Hong, Li Guisen, Zhang Ping, Wang Caili, Xiong Zuying, Xu Gang, Wang Rong, Li Rongshan and 22 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Zhao XinjuDepartment of Nephrology, Peking University People's Hospital, Unit 10C in Ward Building, 11 Xizhimennan Street, Xicheng District, Beijing, 100044, China.
Xing ChangyingDepartment of Nephrology, Jiangsu Province Hospital, Nanjing, China.
Liu HongDepartment of Nephrology, The Second Xiangya Hospital of Central South University, Xiangya, China.
Li GuisenDepartment of Nephrology, Sichuan Academy of Medical Sciences Sichuan People's Hospital, Chengdu, China.
Zhang PingDepartment of Nephrology, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China.
Wang CailiDepartment of Nephrology, The First Affiliated Hospital of Baotou Medical College, Baotou, China.
Xiong ZuyingDepartment of Nephrology, Peking University ShenZhen Hospital, Shenzhen, China.
Xu GangDepartment of Nephrology, Tongji Hospital, Tongji Medical College of HUST, Tongji, China.
Wang RongDepartment of Nephrology, Shandong Provincial Hospital, Jinan, China.
Li RongshanDepartment of Nephrology, Shanxi Provincial People's Hospital, Shanxi, China.
Jiang AiliDepartment of Nephrology, Second Hospital, Tianjin Medical University, Tianjin, China.
Jiang HongliDepartment of Nephrology, The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
Wan JianxinDepartment of Nephrology, The First Affiliated Hospital of Fujian Medical University, Fujian, China.
Wang XiaolingDepartment of Nephrology, Lanzhou University Second Hospital, Lanzhou, China.
Yang JingDepartment of Nephrology, Heifei First People's Hospital, Heifei, China.
Yao LiDepartment of Nephrology, The First Hospital of China Medical University, Shenyang, China.
Wang PeiDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhang RuiDepartment of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Liao YunhuaDepartment of Nephrology, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China.
Luo HuiminDepartment of Nephrology, The First People's Hospital of Yunnan Province, Kunming, China.
Xu JinshengDepartment of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei, China.
Chen MenghuaDepartment of Nephrology, General Hospital of Ninigxia Medical School, Ninigxia, China.
Li YinhuiDepartment of Nephrology, Jilin Province FAW General Hospital, Jilin, China.
Chen QinkaiDepartment of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yuan ZhongfeiDepartment of Nephrology, The People's Hospital of Kaizhou district, Kaizhou, China.
Zha YanDepartment of Nephrology, Guizhou Provincial People's Hospital, Guiyang, China.
Li HongDepartment of Nephrology, Hainan General Hospital, Haikou, China.
Hu WenboDepartment of Nephrology, Qinghai Provincial People's Hospital, Xining, China.
Lu ChenDepartment of Nephrology, Xinjiang Uiger Municipal People's Hospital, Xinjiang, China.
Ni ZhaohuiDepartment of Nephrology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gao LinglingClinical Research Institute, Peking University, Beijing, China.
Zuo LiDepartment of Nephrology, Peking University People's Hospital, Unit 10C in Ward Building, 11 Xizhimennan Street, Xicheng District, Beijing, 100044, China. zuoli@bjmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visualize-HD study aimed to examine prevalence of hyperkalemia (HK), associated practice patterns, and mortality in Chinese patients undergoing hemodialysis (HD). The study included patients aged ≥ 18 years and undergoing chronic HD for ≥ 3 months. Primary outcome was to examine the association between suspected risk factors and HK prevalence at the HD facility level. Secondary outcomes were to determine the HK prevalence, management pattern of serum potassium (sK), and risk factors associated with crude mortality. Overall, 50,983 patients undergoing HD from 231 HD centers were enrolled. HK prevalence (sK > 5.0 mmol/L) in patients undergoing HD was 40.84%. Proportion of patients sK > 5.5, > 6.0, > 6.5 mmol/L was 20.42%, 8.7%, and 3.21%, respectively. Three-year cumulative mortality of patients undergoing HD was 21.3%. Notably,  36.7% of deceased patients had HK as indicated by their final sK

Indexed as

HyperkalemiaRenal DialysisAdultAgedChinaEast Asian PeopleFemaleHumansMaleMiddle AgedPotassiumPrevalenceRisk FactorsPotassiumFacility levelHemodialysisHyperkalemiaSerum potassium

Identifiers

PMID40596462
PMCPMC12217011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.